Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5077| Title: | Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease | Authors: | Eves, N. D. Wainwright, C. Piper, A. Jo, H. E. Corte, T. J. Wort, S. J. |
Issue Date: | 2016 | Source: | 21, (3), 2016, p. 556-566 | Pages: | 556-566 | Journal: | Respirology | Abstract: | L6087462562016-03-08 | DOI: | 10.1111/resp.12749 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L608746256&from=exporthttp://dx.doi.org/10.1111/resp.12749 | | Keywords: | pirfenidone;artificial ventilation;bacterial infection;cystic fibrosis;disease association;drug response;fibrosing alveolitis;forced expiratory volume;functional assessment;gene therapy;genetic analysis;genotype;histopathology;human;interstitial lung disease;Loeffler pneumonia;lung biopsy;lung clearance;lung function;lung injury;mental health;microbiology;patient compliance;pediatrics;phase 3 clinical trial (topic);portopulmonary hypertension;positive end expiratory pressure ventilation;priority journal;pulmonary arteriovenous fistula;pulmonary hypertension;pulmonary vascular disease;respiratory tract inflammation;review;single nucleotide polymorphism;sleep;sleep disordered breathing;cystic fibrosis transmembrane conductance regulator;ivacaftor;acetylcysteinebiological marker;corticosteroid;lumacaftor;nintedanib | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.